PharmaShots | Incisive News in 3 Shots

Subscribe Now

Incytes

Incyte's Opzelura (ruxolitinib) Receives the US FDA's Approval for the Treatment of Vitiligo

Incyte's Opzelura (ruxolitinib) Receives the US FDA's Approval for the Treatment of Vitiligo

July 19, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us